It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
TUBB4A-associated disorder is a rare condition affecting the central nervous system. It displays a wide phenotypic spectrum, ranging from isolated late-onset torsion dystonia to a severe early-onset disease with developmental delay, neurological deficits, and atrophy of the basal ganglia and cerebellum, therefore complicating variant interpretation and phenotype prediction in patients carrying TUBB4A variants. We applied entropy-based normal mode analysis (NMA) to investigate genotype–phenotype correlations in TUBB4A-releated disease and to develop an in-silico approach to assist in variant interpretation and phenotype prediction in this disorder. Variants included in our analysis were those reported prior to the conclusion of data collection for this study in October 2019. All TUBB4A pathogenic missense variants reported in ClinVar and Pubmed, for which associated clinical information was available, and all benign/likely benign TUBB4A missense variants reported in ClinVar, were included in the analysis. Pathogenic variants were divided into five phenotypic subgroups. In-silico point mutagenesis in the wild-type modeled protein structure was performed for each variant. Wild-type and mutated structures were analyzed by coarse-grained NMA to quantify protein stability as entropy difference value (ΔG) for each variant. Pairwise ΔG differences between all variant pairs in each structural cluster were calculated and clustered into dendrograms. Our search yielded 41 TUBB4A pathogenic variants in 126 patients, divided into 11 partially overlapping structural clusters across the TUBB4A protein. ΔG-based cluster analysis of the NMA results revealed a continuum of genotype–phenotype correlation across each structural cluster, as well as in transition areas of partially overlapping structural clusters. Benign/likely benign variants were integrated into the genotype–phenotype continuum as expected and were clearly separated from pathogenic variants. We conclude that our results support the incorporation of the NMA-based approach used in this study in the interpretation of variant pathogenicity and phenotype prediction in TUBB4A-related disease. Moreover, our results suggest that NMA may be of value in variant interpretation in additional monogenic conditions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Beilinson Hospital, Raphael Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Israel (GRID:grid.413156.4) (ISNI:0000 0004 0575 344X); Beilinson Hospital, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel (GRID:grid.413156.4) (ISNI:0000 0004 0575 344X)
2 Beilinson Hospital, Raphael Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Israel (GRID:grid.413156.4) (ISNI:0000 0004 0575 344X); Tel-Aviv University, Sackler Faculty of Medicine, Tel-Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546)
3 Tel-Aviv University, Sackler Faculty of Medicine, Tel-Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546); Wolfson Medical Center, Metabolic-Neurogenetic Clinic, Holon, Israel (GRID:grid.414317.4) (ISNI:0000 0004 0621 3939); Wolfson Medical Center, Rina Mor Institute of Medical Genetics, Holon, Israel (GRID:grid.414317.4) (ISNI:0000 0004 0621 3939)
4 Beilinson Hospital, Raphael Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Israel (GRID:grid.413156.4) (ISNI:0000 0004 0575 344X); Tel-Aviv University, Sackler Faculty of Medicine, Tel-Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546); Felsenstein Medical Research Center, Petah Tikva, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546)
5 Beilinson Hospital, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel (GRID:grid.413156.4) (ISNI:0000 0004 0575 344X); Tel-Aviv University, Sackler Faculty of Medicine, Tel-Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546); Felsenstein Medical Research Center, Petah Tikva, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546)